Furthermore, almost 5% of patients with lung carcinoids have MEN1 syndrome harboring a germinal mutation of this gene; in these cases, family history, clinical examination and laboratory tests like calcium, parathyroid hormone (PTH) and prolactin should be performed as well as a screening for mutational analysis [14–16]. This evidence concerns the gene PTH and lung carcinoid tumor.